Opko Health, Inc.
OPK
$1.90
$0.010.53%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.95% | -2.78% | -31.36% | -26.89% | -1.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.95% | -2.78% | -31.36% | -26.89% | -1.85% |
| Cost of Revenue | -17.36% | 7.93% | -1.58% | -10.16% | 5.18% |
| Gross Profit | 114.25% | -59.78% | -74.55% | -69.80% | -30.58% |
| SG&A Expenses | -8.03% | 35.94% | -13.75% | -7.24% | -1.51% |
| Depreciation & Amortization | -5.33% | -5.11% | -5.18% | -0.17% | -0.32% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.62% | 15.07% | -5.64% | -8.54% | 2.67% |
| Operating Income | 52.01% | -63.70% | -982.13% | -134.66% | -16.87% |
| Income Before Tax | 148.24% | 161.76% | 35.82% | -388.35% | 29.06% |
| Income Tax Expenses | 448.00% | 287.28% | -108.89% | -209.49% | 64.54% |
| Earnings from Continuing Operations | 121.10% | 129.47% | 47.53% | -348.00% | 22.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 121.10% | 129.47% | 47.53% | -348.00% | 22.00% |
| EBIT | 52.01% | -63.70% | -982.13% | -134.66% | -16.87% |
| EBITDA | 78.88% | -111.97% | -211.86% | -1,037.89% | -32.02% |
| EPS Basic | 123.39% | 131.85% | 43.30% | -376.54% | 22.10% |
| Normalized Basic EPS | 273.44% | -80.91% | 196.43% | -425.71% | 55.53% |
| EPS Diluted | 119.28% | 128.29% | 43.30% | -376.54% | 19.63% |
| Normalized Diluted EPS | 223.31% | -25.84% | 196.43% | -425.71% | 55.53% |
| Average Basic Shares Outstanding | -9.94% | -7.57% | -7.25% | -5.94% | 0.18% |
| Average Diluted Shares Outstanding | 26.66% | 32.85% | -7.25% | -5.94% | 0.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
